Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Financial Information

Quarterly Results

Q1
Q2
Q3
Q4
Board Meeting Intimation
Press Release
Financial Results
Fact Sheet
IR Call Invite
Investor Presentation
IR Call Transcript
Share Holding Pattern
IR Call Audio
Subsidiary Financials
Annual Report 2024-25
Q1
Q2
Q3
Q4
Board Meeting Intimation
Press Release
Financial Results
Fact Sheet
IR Call Invite
Investor Presentation
IR Call Transcript
Share Holding Pattern
IR Call Audio
Subsidiary Financials
Annual Report 2023-24
Q1
Q2
Q3
Q4
Board Meeting Intimation
Press Release
Financial Results
Fact Sheet
IR Call Invite
Investor Presentation
IR Call Transcript
Share Holding Pattern
IR Call Audio
Subsidiary Financials
Annual Report 2022-23
Q1
Q2
Q3
Q4
Board Meeting Intimation
Press Release
Financial Results
Fact Sheet
IR Call Invite
Investor Presentation
IR Call Transcript
Share Holding Pattern
IR Call Audio
Subsidiary Financials
Annual Report 2021-22
Q1
Q2
Q3
Q4
Board Meeting Intimation
Press Release
Financial Results
Fact Sheet
IR Call Invite
Investor Presentation
IR Call Transcript
Share Holding Pattern
Subsidiary Financials
Annual Report 2020-21
Q1
Q2
Q3
Q4
Board Meeting Intimation
Press Release
Financial Results
Fact Sheet
IR Call Invite
Investor Presentation
IR Call Transcript
Share Holding Pattern
Subsidiary Financials
Annual Report 2019-20
Q1
Q2
Q3
Q4
Press Release
Financial Results
Fact Sheet
IR Call Invite
Investor Presentation
IR Call Transcript
Share Holding Pattern
Subsidiary Financials
Annual Report 2018-19
Q1
Q2
Q3
Q4
Press Release
Financial Results
Fact Sheet
Investor Conference Call Invite
Investor Presentation
IR Call transcript
Share Holding Pattern
Subsidiary Financials
Annual Report 2017-2018
Q1
Q2
Q3
Q4
Press Release
Financial Results
Fact Sheet
Investor Conference Call Invite
Investor Presentation
IR Call transcript
Share Holding Pattern
Annual Report 2016-2017
Q1
Q2
Q3
Q4
Financial Results
Fact Sheet
Investor Presentation
Conference Call Transcript
Share Holding Pattern
Annual Report

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details